Marshall Wace’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,096
| Closed | -$2.08M | – | 4550 |
|
|
2021
Q3 | $2.08M | Buy |
+12,096
| New | +$1.58M | 0.01% | 1511 |
|
|
2021
Q2 | – | Sell |
-6,542
| Closed | -$887K | – | 3447 |
|
|
2021
Q1 | $887K | Buy |
6,542
+1,023
| +19% | +$132K | ﹤0.01% | 1724 |
|
|
2020
Q4 | $706K | Buy |
+5,519
| New | +$647K | ﹤0.01% | 1346 |
|
|
2020
Q3 | – | Sell |
-3,162
| Closed | -$301K | – | 2051 |
|
|
2020
Q2 | $301K | Buy |
3,162
+1,539
| +95% | +$148K | ﹤0.01% | 1331 |
|
|
2020
Q1 | $146K | Buy |
+1,623
| New | +$126K | ﹤0.01% | 1252 |
|
|
2019
Q2 | – | Sell |
-208,333
| Closed | -$9.7M | – | 2013 |
|
|
2019
Q1 | $9.7M | Buy |
208,333
+207,304
| +20,146% | +$9.1M | 0.09% | 268 |
|
|
2018
Q4 | $45K | Buy |
+1,029
| New | +$51.4K | ﹤0.01% | 1458 |
|
|
2016
Q4 | – | Sell |
-15,684
| Closed | -$568K | – | 1173 |
|
|
2016
Q3 | $568K | Buy |
+15,684
| New | +$520K | ﹤0.01% | 793 |
|
Marshall Wace's XLRN Position: Q4 2021 in Review
Marshall Wace sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 12,096 shares — an estimated $2.08M sold.
Marshall Wace first reported a position in XLRN in Q3 2016 and held it in 8 quarters. The position peaked at $9.7M in Q1 2019. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Marshall Wace reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Marshall Wace sold 12,096 Acceleron Pharma shares in Q4 2021, an estimated $2.08M.
- Marshall Wace first reported a position in Acceleron Pharma in Q3 2016 and held it in 8 quarters.
- Marshall Wace's Acceleron Pharma position peaked at $9.7M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.